Clinical Trial News Archive

Get news By email or subscribe to our News feeds.

August 2009

August 5

First Human Demonstration of Significant, Persistent Antibody Response Using Electroporation-Delivered DNA Vaccine Published in Human Gene Therapy Phase Forward to Present at the 11th Annual Pacific Crest Technology Leadership Forum Results From TH-302 Clinical Trials Presented at International Lung Cancer Meeting Clinical Data Evaluating Amrubicin as Potential Therapy for Patients with Small Cell Lung Cancer Presented at 13th World Conference on Lung Cancer Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis RXi Pharmaceuticals Presented Data from Animal Trials Demonstrating the Utility of Self-Delivering RNAi at IBC's Oligonucleotide Therapeutics Conference GeoVax Labs, Inc. Provides Clinical Studies Update M. D. Anderson Study Finds Common Diabetic Therapy Reduces Risk of Pancreatic Cancer Heartbeat's Bill Drummy Will Be Featured at HBA -- The Beauty Event in New York City The Group Room to Broadcast Live from the 13th World Conference on Lung Cancer Data Demonstrate New Imiquimod Formulation as Short Course Treatment for Actinic Keratosis MIXX 2009 To Showcase Powerful Roster of the Best Minds Fueling Interactive's Creative Revolution FDA Accepts NDA for New Imiquimod Product

August 6

Scientific Article Outlines Role of Galectin-3 in Heart Failure Development and Progression Med Ad News? PharmaMed Marketing & Media Conference Announces Updates to the Three Innovative Sales-Force-Effectiveness, Digital Marketing & Patient Centered Communication Tracks Galapagos NV (BE) - Galapagos successfully completes first Phase I study for GLPG0259 Opaxio Combined with Alimta Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer Quark Pharmaceuticals to Participate in IBC's Oligonucleotide Therapeutics: From Concept to Implementation Conference Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome Journal of Clinical Oncology Publishes TREANDA Study Demonstrating Significant Improvement in Overall Response and Progression-Free Survival in Chronic Lymphocytic Leukemia Alzheimer's Disease is the Focus of TBSI Annual Neuroscience Symposium

August 11

Knopp Neurosciences to Present Phase 2 Results of KNS-760704 in ALS AVANIR Announces Positive Phase III Study Results for Zenvia Array BioPharma Reports Positive Results of Its Oral Glucokinase Activator in Type 2 Diabetes Patients Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals' Lead Antibody Javelin Pharmaceuticals Reports Ereska (Intranasal Ketamine) Phase III Trial Results in Postoperative Orthopedic Pain Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss AVANIR Pharmaceuticals Schedules Conference Call to Discuss Phase III Results for Zenvia in Pseudobulbar Affect As Aging Populations Rise, World-Renowned Aging Experts Will Convene to Share Insights into How to Achieve a Healthy Lifespan Pluristem Therapeutics Will Present the Phase I Study for PLX-PAD in Critical Limb Ischemia at MSC2009 Regenerative Medicine and Adult Stem Cell Therapy Conference Endocyte Announces Positive Results from a Phase II Clinical Study of EC145 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Romaco at PackExpo in Las Vegas

August 12

NanoViricides, Inc. Herpes Study Results Discussed on CBS News Report Endocyte announces positive results from a Phase II clinical study of EC145 in patients with advanced non-small cell lung cancer (NSCLC) Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse® (lisdexamfetamine dimesylate) CII Provided Significant Improvement of ADHD Symptoms for Children at 13 Hours After Administration ANA773 Demonstrates Significant Antiviral Response in Early Clinical Trial in Hepatitis C Patients Omeros Announces Positive Clinical Results of Phase 1/Phase 2 Trial of OMS302 for Use During Ophthalmologic Surgery Accera Announces Peer-Reviewed Publication of the Results of its 90-Day Clinical Study of AC-1202 (Axona ) in Mild to Moderate Alzheimer's Disease CytRx's Drug Candidate INNO-206 Produces Statistically Significant Tumor Shrinkage in Animal Model of Small Cell Lung Cancer Palatin Technologies, Inc. Reports Positive Bremelanotide Study; Improved Safety Profile with Subcutaneous Administration NuPathe Reports Positive Phase III Results for Zelrix, a Novel Transdermal Patch for Acute Migraine

August 19

Forest Announces Phase IIb Study Results For Oglemilast in Chronic Obstructive Pulmonary Disease PCI Biotech Holding (NO) - Anti-tumour drug more potent with light-directed delivery Gentium Reports Top Line Results from the Phase III Treatment Trial of Defibrotide for Severe Veno-Occlusive Disease Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis Novavax Virus-Like Particle Vaccine Protects Against 2009 Pandemic H1N1 Influenza Virus Lilly Reports on Outcome of Phase III Study of Arzoxifene Gentium Reports Top Line Results from the Phase III Treatment Trial of Defibrotide for Severe Veno-Occlusive Disease Study Examines Adverse Events Associated With Human Papillomavirus Vaccine Ablynx Announces Positive Phase I Results for Subcutaneous Administration of it's Ant-thrombotic NanobodyR (ALX-0681)

August 26

BioAlliance Pharma Announces Positive Preliminary Pivotal Phase III Results in Herpes Labialis with Acyclovir Lauriad Lurasidone Demonstrated Efficacy in Treating Patients With Schizophrenia in Pivotal Phase 3 Study Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once-Daily Xibrom(TM) 0.09% Long-term tamoxifen use increases risk of an aggressive, hard to treat type of second breast cancer Hormone Therapy for Prostate Cancer Patients With Certain Heart Conditions Associated With Increased Risk of Death Genetic Variation Associated With Poorer Response, Cardiovascular Outcomes With Use of Clopidogrel Comparative Effectiveness Research Study in Mayo Clinic Proceedings Demonstrated Asthma Patients Had Better Overall Results with Oral Controllers than Inhaled Products NovaBay Pharmaceuticals to Present New Pre-Clinical Data on Lead Anti-Infective Compound for use in Onychomycosis at the 2009 IDSA Annual Meeting MoxDuo IR Demonstrates Fewer Side Effects Than Percocet Genmab Announces Positive Top-Line Results for Arzerra in Front Line NHL Nymox's NX-1207 Shows Major Effect on Liver Cancer New Data Published in the Journal Population Health Management Show Significant Misuse of Pain Medication Among Chronic Pain Population

August 28

Four Studies Published in The Lancet Show Roflumilast (Daxas), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations Forest Laboratories, Inc. and Nycomed Announce a Conference Call to Review Publication of Daxas Phase III Clinical Trial Results Blood Thinner Causes Stroke in Some Dialysis Patients Nycomed/Forest - Ph III Data Published in The Lancet Showing that Roflumilast (Daxas), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of Cardiology Congress 2009 BioAlliance Pharma to present at the French-Norwegian Interdisciplinary Symposium on Nano and Micro Frontiers in Biology and Medicine (Bergen, Norway, August 31 to September 2, 2009)
(web6)